vs

Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.

LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $270.6M, roughly 1.4× Astera Labs, Inc.). Astera Labs, Inc. runs the higher net margin — 16.6% vs 3.1%, a 13.6% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 17.4%). Astera Labs, Inc. produced more free cash flow last quarter ($76.6M vs $46.6M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 12.8%).

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

ALAB vs LFST — Head-to-Head

Bigger by revenue
LFST
LFST
1.4× larger
LFST
$382.2M
$270.6M
ALAB
Growing faster (revenue YoY)
ALAB
ALAB
+74.3% gap
ALAB
91.8%
17.4%
LFST
Higher net margin
ALAB
ALAB
13.6% more per $
ALAB
16.6%
3.1%
LFST
More free cash flow
ALAB
ALAB
$29.9M more FCF
ALAB
$76.6M
$46.6M
LFST
Faster 2-yr revenue CAGR
ALAB
ALAB
Annualised
ALAB
103.6%
12.8%
LFST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALAB
ALAB
LFST
LFST
Revenue
$270.6M
$382.2M
Net Profit
$45.0M
$11.7M
Gross Margin
75.6%
Operating Margin
24.7%
4.7%
Net Margin
16.6%
3.1%
Revenue YoY
91.8%
17.4%
Net Profit YoY
82.0%
264.1%
EPS (diluted)
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALAB
ALAB
LFST
LFST
Q4 25
$270.6M
$382.2M
Q3 25
$230.6M
$363.8M
Q2 25
$191.9M
$345.3M
Q1 25
$159.4M
$333.0M
Q4 24
$141.1M
$325.5M
Q3 24
$113.1M
$312.7M
Q2 24
$76.8M
$312.3M
Q1 24
$65.3M
$300.4M
Net Profit
ALAB
ALAB
LFST
LFST
Q4 25
$45.0M
$11.7M
Q3 25
$91.1M
$1.1M
Q2 25
$51.2M
$-3.8M
Q1 25
$31.8M
$709.0K
Q4 24
$24.7M
$-7.1M
Q3 24
$-7.6M
$-6.0M
Q2 24
$-7.5M
$-23.3M
Q1 24
$-93.0M
$-21.1M
Gross Margin
ALAB
ALAB
LFST
LFST
Q4 25
75.6%
Q3 25
76.2%
Q2 25
75.8%
Q1 25
74.9%
Q4 24
74.0%
Q3 24
77.7%
Q2 24
77.9%
Q1 24
77.4%
Operating Margin
ALAB
ALAB
LFST
LFST
Q4 25
24.7%
4.7%
Q3 25
24.0%
2.0%
Q2 25
20.7%
-0.9%
Q1 25
7.1%
0.5%
Q4 24
0.1%
0.3%
Q3 24
-7.9%
0.0%
Q2 24
-31.7%
-5.1%
Q1 24
-127.1%
-5.6%
Net Margin
ALAB
ALAB
LFST
LFST
Q4 25
16.6%
3.1%
Q3 25
39.5%
0.3%
Q2 25
26.7%
-1.1%
Q1 25
20.0%
0.2%
Q4 24
17.5%
-2.2%
Q3 24
-6.7%
-1.9%
Q2 24
-9.8%
-7.5%
Q1 24
-142.5%
-7.0%
EPS (diluted)
ALAB
ALAB
LFST
LFST
Q4 25
$0.25
Q3 25
$0.50
Q2 25
$0.29
Q1 25
$0.18
Q4 24
$1.23
Q3 24
$-0.05
Q2 24
$-0.05
Q1 24
$-1.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALAB
ALAB
LFST
LFST
Cash + ST InvestmentsLiquidity on hand
$167.6M
$248.6M
Total DebtLower is stronger
$282.8M
Stockholders' EquityBook value
$1.4B
$1.5B
Total Assets
$1.5B
$2.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALAB
ALAB
LFST
LFST
Q4 25
$167.6M
$248.6M
Q3 25
$140.4M
$203.9M
Q2 25
$162.3M
$188.9M
Q1 25
$86.4M
$134.3M
Q4 24
$79.6M
$154.6M
Q3 24
$126.1M
$102.6M
Q2 24
$421.1M
$87.0M
Q1 24
$696.1M
$49.5M
Total Debt
ALAB
ALAB
LFST
LFST
Q4 25
$282.8M
Q3 25
$284.6M
Q2 25
$286.4M
Q1 25
$288.2M
Q4 24
$290.0M
Q3 24
$287.3M
Q2 24
$288.0M
Q1 24
$288.8M
Stockholders' Equity
ALAB
ALAB
LFST
LFST
Q4 25
$1.4B
$1.5B
Q3 25
$1.3B
$1.5B
Q2 25
$1.1B
$1.5B
Q1 25
$1.0B
$1.5B
Q4 24
$964.8M
$1.4B
Q3 24
$889.6M
$1.4B
Q2 24
$845.3M
$1.4B
Q1 24
$808.8M
$1.4B
Total Assets
ALAB
ALAB
LFST
LFST
Q4 25
$1.5B
$2.2B
Q3 25
$1.4B
$2.1B
Q2 25
$1.3B
$2.1B
Q1 25
$1.1B
$2.1B
Q4 24
$1.1B
$2.1B
Q3 24
$983.1M
$2.1B
Q2 24
$915.5M
$2.1B
Q1 24
$864.9M
$2.1B
Debt / Equity
ALAB
ALAB
LFST
LFST
Q4 25
0.19×
Q3 25
0.19×
Q2 25
0.19×
Q1 25
0.20×
Q4 24
0.20×
Q3 24
0.20×
Q2 24
0.20×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALAB
ALAB
LFST
LFST
Operating Cash FlowLast quarter
$95.3M
$57.6M
Free Cash FlowOCF − Capex
$76.6M
$46.6M
FCF MarginFCF / Revenue
28.3%
12.2%
Capex IntensityCapex / Revenue
6.9%
2.9%
Cash ConversionOCF / Net Profit
2.12×
4.93×
TTM Free Cash FlowTrailing 4 quarters
$281.8M
$110.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALAB
ALAB
LFST
LFST
Q4 25
$95.3M
$57.6M
Q3 25
$78.2M
$27.3M
Q2 25
$135.4M
$64.4M
Q1 25
$10.5M
$-3.1M
Q4 24
$39.7M
$62.3M
Q3 24
$63.5M
$22.7M
Q2 24
$29.8M
$44.1M
Q1 24
$3.7M
$-21.8M
Free Cash Flow
ALAB
ALAB
LFST
LFST
Q4 25
$76.6M
$46.6M
Q3 25
$65.9M
$17.0M
Q2 25
$133.3M
$56.6M
Q1 25
$6.0M
$-10.3M
Q4 24
$24.3M
$56.0M
Q3 24
$46.8M
$17.7M
Q2 24
$28.5M
$39.0M
Q1 24
$228.0K
$-26.9M
FCF Margin
ALAB
ALAB
LFST
LFST
Q4 25
28.3%
12.2%
Q3 25
28.6%
4.7%
Q2 25
69.5%
16.4%
Q1 25
3.7%
-3.1%
Q4 24
17.2%
17.2%
Q3 24
41.4%
5.7%
Q2 24
37.1%
12.5%
Q1 24
0.3%
-9.0%
Capex Intensity
ALAB
ALAB
LFST
LFST
Q4 25
6.9%
2.9%
Q3 25
5.3%
2.8%
Q2 25
1.1%
2.2%
Q1 25
2.8%
2.2%
Q4 24
10.9%
1.9%
Q3 24
14.8%
1.6%
Q2 24
1.7%
1.6%
Q1 24
5.2%
1.7%
Cash Conversion
ALAB
ALAB
LFST
LFST
Q4 25
2.12×
4.93×
Q3 25
0.86×
25.34×
Q2 25
2.64×
Q1 25
0.33×
-4.36×
Q4 24
1.61×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons